Comparison of 4.54% Hypertonic Saline and 20% Mannitol for Brain Relaxation During Auditory Brainstem Implantation in Pediatric Patients: a Single-center Retrospective Observational Cohort Study

Overview

Journal BMC Surg

Publisher Biomed Central

Specialty General Surgery

Date 2024 Oct 30

PMID 39472910

Authors

Hao Fan

Linhong Zhong

Huan Jia

Jinya Shi

Jingjie Li

Affiliations

Soon will be listed here.

Abstract

Background: Mannitol is frequently utilized to achieve intracranial brain relaxation during the retrosigmoid approach for auditory brainstem implantation (ABI). Hypertonic saline (HS) is an alternative for reducing intracranial pressure; however, its application during ABI surgery remains under-investigated. We aimed to compare the efficacy and safety between HS and mannitol for maintaining brain relaxation.

Methods: This single-center retrospective cohort study included pediatric patients undergoing ABI surgery from September 2020 to January 2022 who received only 4.54% HS or 20% mannitol for brain relaxation. The analysis involved initial doses, subsequent doses, and dosing intervals of the two hyperosmolar solutions, as well as the time elapsed from meningeal opening to the first ABI electrode placement attempt. Additionally, the analysis encompassed electrolyte testing, hemodynamic variables, urine output, blood transfusion, second surgeries, adverse events, intensive care unit length of stay, and 30-day mortality.

Results: We analyzed 68 consecutive pediatric patients; 26 and 42 in the HS and mannitol groups, respectively. The HS group exhibited a reduced rate of supplementary use (7.7% vs. 31%) and lower total urine volume. Perioperative outcomes, mortality, and length of intensive care unit stay did not exhibit significant between-group differences, despite transient increases in blood sodium and chloride observed within 2 h after HS infusion.

Conclusions: In pediatric ABI surgery, as an osmotherapy for cerebral relaxation, 4.54% HS demonstrated a lower likelihood of necessitating additional supplementation than 20% mannitol. Furthermore, the diuretic effect of HS was weak and the increase in electrolyte levels during surgery was temporary and slight.

References

Egra-Dagan D, van Beurden I, Barber S, Carter C, Cunnane M, Christian Brown M . Adult Auditory Brainstem Implant Outcomes and Three-Dimensional Electrode Array Position on Computed Tomography. Ear Hear. 2021; 42(6):1741-1754. DOI: 10.1097/AUD.0000000000001064. View

Li Q, Chen H, Hao J, Yin N, Xu M, Zhou J . Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double-blinded, randomised controlled trial. BMC Anesthesiol. 2015; 15:138. PMC: 4596287. DOI: 10.1186/s12871-015-0119-4. View

Noij K, Kozin E, Sethi R, Shah P, Kaplan A, Herrmann B . Systematic Review of Nontumor Pediatric Auditory Brainstem Implant Outcomes. Otolaryngol Head Neck Surg. 2015; 153(5):739-50. DOI: 10.1177/0194599815596929. View

Colletti V, Carner M, Fiorino F, Sacchetto L, Miorelli V, Orsi A . Hearing restoration with auditory brainstem implant in three children with cochlear nerve aplasia. Otol Neurotol. 2002; 23(5):682-93. DOI: 10.1097/00129492-200209000-00014. View

Shao L, Hong F, Zou Y, Hao X, Hou H, Tian M . Hypertonic saline for brain relaxation and intracranial pressure in patients undergoing neurosurgical procedures: a meta-analysis of randomized controlled trials. PLoS One. 2015; 10(1):e0117314. PMC: 4311961. DOI: 10.1371/journal.pone.0117314. View

Kheirbek T, Pascual J . Hypertonic saline for the treatment of intracranial hypertension. Curr Neurol Neurosci Rep. 2014; 14(9):482. DOI: 10.1007/s11910-014-0482-4. View

Fayad J, Otto S, Brackmann D . Auditory brainstem implants: surgical aspects. Adv Otorhinolaryngol. 2006; 64:144-153. DOI: 10.1159/000094649. View

Susanto M, Riantri I . Optimal Dose and Concentration of Hypertonic Saline in Traumatic Brain Injury: A Systematic Review. Medeni Med J. 2022; 37(2):203-211. PMC: 9234368. DOI: 10.4274/MMJ.galenos.2022.75725. View

Li J, Gelb A, Flexman A, Ji F, Meng L . Definition, evaluation, and management of brain relaxation during craniotomy. Br J Anaesth. 2016; 116(6):759-69. DOI: 10.1093/bja/aew096. View

10.

Shackford S, Bourguignon P, Wald S, Rogers F, Osler T, Clark D . Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial. J Trauma. 1998; 44(1):50-8. DOI: 10.1097/00005373-199801000-00004. View

11.

Rozet I, Tontisirin N, Muangman S, Vavilala M, Souter M, Lee L . Effect of equiosmolar solutions of mannitol versus hypertonic saline on intraoperative brain relaxation and electrolyte balance. Anesthesiology. 2007; 107(5):697-704. DOI: 10.1097/01.anes.0000286980.92759.94. View

12.

Tsaousi G, Pezikoglou I, Nikopoulou A, Foroglou N, Poulopoulou A, Vyzantiadis T . Comparison of Equiosmolar Doses of 7.5% Hypertonic Saline and 20% Mannitol on Cerebral Oxygenation Status and Release of Brain Injury Markers During Supratentorial Craniotomy: A Randomized Controlled Trial. J Neurosurg Anesthesiol. 2021; 35(1):56-64. DOI: 10.1097/ANA.0000000000000791. View

13.

Kumar A, Shi Y, Shotwell M, Richards J, Ehrenfeld J . Hypernatremia is a significant risk factor for acute kidney injury after subarachnoid hemorrhage: a retrospective analysis. Neurocrit Care. 2014; 22(2):184-91. DOI: 10.1007/s12028-014-0067-8. View

14.

Liu S, Li L, Luo Z, Wang M, She H, Yu X . Superior effect of hypertonic saline over mannitol to attenuate cerebral edema in a rabbit bacterial meningitis model. Crit Care Med. 2011; 39(6):1467-73. DOI: 10.1097/CCM.0b013e3182120d13. View

15.

Tsaousi G, Stazi E, Cinicola M, Bilotta F . Cardiac output changes after osmotic therapy in neurosurgical and neurocritical care patients: a systematic review of the clinical literature. Br J Clin Pharmacol. 2017; 84(4):636-648. PMC: 5867072. DOI: 10.1111/bcp.13492. View

16.

Abdulhamid A, Ghaddaf A, Bokhari A, Alghamdi Y, Alhakami M, Alaboud A . Equiosmolar hypertonic saline and mannitol for brain relaxation in patients undergoing supratentorial tumor surgery: A systematic review and meta-analysis. Surg Neurol Int. 2022; 13:120. PMC: 9062934. DOI: 10.25259/SNI_136_2022. View

17.

Kim M, Park J, Kang N, Jang H, Lee J, Huh W . Increased risk of acute kidney injury associated with higher infusion rate of mannitol in patients with intracranial hemorrhage. J Neurosurg. 2014; 120(6):1340-8. DOI: 10.3171/2013.12.JNS13888. View

18.

Kochanek P, Carney N, Adelson P, Ashwal S, Bell M, Bratton S . Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents--second edition. Pediatr Crit Care Med. 2012; 13 Suppl 1:S1-82. DOI: 10.1097/PCC.0b013e31823f435c. View

19.

Narayan S, Castelino R, Hammond N, Patanwala A . Effect of mannitol plus hypertonic saline combination versus hypertonic saline monotherapy on acute kidney injury after traumatic brain injury. J Crit Care. 2020; 57:220-224. DOI: 10.1016/j.jcrc.2020.03.006. View

20.

Fang J, Yang Y, Wang W, Liu Y, An T, Zou M . Comparison of equiosmolar hypertonic saline and mannitol for brain relaxation during craniotomies: A meta-analysis of randomized controlled trials. Neurosurg Rev. 2017; 41(4):945-956. DOI: 10.1007/s10143-017-0838-8. View